Ferric Maltol
Indication
Iron Deficiency Anaemia in Adult Patients with Inflammatory Bowel Disease
Black
Brand:
Feraccru®
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Blood and Nutrition
Background
Ferric maltol 30mg capsules (Feraccru®) are not recommended for the treatment of iron deficiency anaemia (IDA) in patients with inflammatory bowel disease (IBD) in the Lancashire and South Cumbria health economies. Further studies assessing the efficacy, safety and cost-effectiveness of ferric maltol versus other iron formulations are required to demonstrate the position of ferric maltol in the treatment pathway of IDA in patients with IBD.
Recommendation
LSCMMG Recommendation:
Black
Reason for decision:
Not recommended for prescribing on the NHS in Lancashire & South Cumbria
Supporting documents: